ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Harnessing engineered NK cells for refractory CD30+ lymphoma.

Yago Nieto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.